Mycobacterial trehalose-containing glycolipid with immunomodulatory activity on human CD4+ and CD8+ T-cells

Microbes and Infection

Volumn 8, Issue 2, 2006, Pages 533-540

  Saavedra, Rafael ^a   Segura, Erika ^a   Tenorio, Eda P ^a   López Marín, Luz M ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Glycolipids; Immune modulation; Mycobacterium tuberculosis

Indexed keywords

2,3 DI O ACYLTREHALOSE; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; GLYCOLIPID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TREHALOSE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MYCOBACTERIUM; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; GLYCOLIPIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, INTERLEUKIN-2; TREHALOSE;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 32244433479     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.08.005     Document Type: Article

References (24)

1. S.H. Kaufmann Protection against tuberculosis: cytokines, T cells, and macrophages Ann. Rheum. Dis. 61 2002 ii54 ii58
2. E.L. Corbett, C.J. Watt, N. Walker, D. Maher, B.G. Williams, M.C. Raviglione, and C. Dye The growing burden o tuberculosis. Global trends and interactions with the HIV epidemic Arch. Intern. Med. 163 2003 1009 1021
3. M. Daff́, and P. Draper The envelope layers of mycobacteria with reference to their pathogenicity Adv. Microb. Physiol. 39 1998 131 203
4. U.E. Schaible, F. Winau, P.A. Sieling, K. Fischer, H.L. Collins, K. Hagens, R.L. Modlin, V. Brinkmann, and S.H. Kaufmann Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis Nat. Med. 9 2003 1039 1046
5. C. Manca, M.B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C.E. Barry III, and G. Kaplan Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis Infect. Immun. 72 2004 5511 5514
6. V. Briken, S.A. Porcelli, G.S. Besra, and L. Kremer Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response Mol. Microbiol. 53 2004 391 403
7. M.B. Reed, P. Domenech, C. Manca, H. Su, A.K. Barczak, B.N. Kreiswirth, G. Kaplan, and C.E. Barry III A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response Nature 431 2004 84 87
8. P. Domenech, M.B. Reed, C.S. Dowd, C. Manca, G. Kaplan, and C.E. Barry III The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis J. Biol. Chem. 279 2004 21257 21265
9. C. Rousseau, O. Neyrolles, Y. Bordat, S. Groux, T.D. Sirakova, M.C. Prevost, P.E. Kolattukudy, B. Gicquel, and M. Jackson Deficiency in mycolipenate- and mycosanoate-derived acyltrehaloses enhances early interactions of Mycobacterium tuberculosis with host cells Cell. Microbiol. 5 2003 405 415
10. R. Saavedra, E. Segura, R. Leyva, L.A. Esparza, and L.M. López-Marín Mycobacterial di-O-acyl-trehalose inhibits mitogen- and antigen-induced proliferation of murine T cells in vitro Clin. Diagn. Lab. Immunol. 8 2001 1081 1088
11. L. Escamilla, R. Mancilla, W. Glender, and L.M. López Marín Mycobacterium fortuitum glycolipids for the serodiagnosis of pulmonary tuberculosis Am. Rev. Respir. Crit. Care Med. 154 1996 1864 1867
12. R. Saavedra, M.A. Becerril, C. Dubeaux, R. Lippens, M.J. De Vos, P. Herion, and A. Bollen Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii Infect. Immun. 64 1996 3858 3862
13. A.B. Lyons, and C.R. Parish Determination of lymphocyte division by flow cytometry J. Immunol. Methods 171 1994 131 137
14. G.S. Besra, R.C. Bolton, M.R. McNeil, M. Ridell, K.E. Simpson, J. Glushka, H. Van Halbeek, P.J. Brennan, and D.E. Minnikin Structural elucidation of a novel family of acyltrehaloses from Mycobacterium tuberculosis Biochemistry 31 1992 9832 9837
15. N. Gautier, L.M. López Marín, M.A. Lańelle, and M. Daff́ Structure of mycoside F, a family of trehalose-containing glycolipids of Mycobacterium fortuitum FEMS Microbiol. Lett. 77 1992 81 87
16. T.B. Geijtenbeek, S.J. Van Vliet, E.A. Koppel, M. Sánchez- Hernández, C.M. Vanderbroucke-Grauls, B. Appelmelk, and Y. Van Kooyk Mycobacteria target DC-SIGN to suppress dendritic cell function J. Exp. Med. 197 2003 7 17
17. G. Vanham, Z. Toossi, C.S. Hirsch, R.S. Wallis, S.K. Schwander, E.A. Rich, and J.J. Ellner Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy Tuberc. Lung Dis. 78 1997 145 158
18. J.L. Flynn, and J. Chan Immunology of tuberculosis Annu. Rev. Immunol. 19 2001 93 129
19. C. Brodskyn, J. Patricio, R. Oliveira, L. Lobo, A. Arnholdt, L. Mendoņa-Previato, A. Barral, and M. Barral-Netto Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses Infect. Immun. 70 2002 3736 3743
20. J.J. Fourní, E. Adams, R.J. Mullins, and A. Basten Inhibition of human lymphoproliferative responses by mycobacterial phenolic glycolipids Infect. Immun. 57 1989 3653 3659
21. C. Moreno, A. Mehlert, and J. Lamb The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation Clin. Exp. Immunol. 74 1988 206 210
22. F. Papa, P. Cruaud, and H.L. David Antigenicity and specificity of selected glycolipid fractions from Mycobacterium tuberculosis Res. Microbiol. 140 1989 569 578
23. S. Ladisch, R. Li, and E. Olson Ceramide structure predicts tumor ganglioside immunosuppressive activity Proc. Natl. Acad. Sci. USA 91 1994 1974 1978
24. S.D.C. Müller, M.R. Müller, M. Huber, D. Esche Uv, C.J. Kirschning, H. Wagner, W.G. Bessler, and K. Mittenbühler Triacyl-lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moieties Int. Immunopharmacol. 4 2004 1287 1300